Stonepine Capital Management as of June 30, 2024
Portfolio Holdings for Stonepine Capital Management
Stonepine Capital Management holds 25 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Adma Biologics (ADMA) | 19.1 | $21M | 1.9M | 11.18 | |
| Alimera Sciences Com New | 17.8 | $20M | 3.5M | 5.56 | |
| Evolus (EOLS) | 16.4 | $18M | 1.7M | 10.85 | |
| Galapagos Nv- Spons Adr (GLPG) | 11.0 | $12M | 485k | 24.78 | |
| Revance Therapeutics (RVNC) | 6.6 | $7.2M | 2.8M | 2.57 | |
| Xoma Corp Com New (XOMA) | 5.4 | $5.9M | 250k | 23.69 | |
| Anika Therapeutics (ANIK) | 3.8 | $4.2M | 165k | 25.33 | |
| Tela Bio (TELA) | 2.7 | $2.9M | 626k | 4.70 | |
| Rigel Pharmaceuticals Com New (RIGL) | 2.3 | $2.5M | 305k | 8.22 | |
| Optinose (OPTN) | 2.2 | $2.4M | 2.4M | 1.04 | |
| Aclaris Therapeutics (ACRS) | 1.9 | $2.1M | 1.9M | 1.10 | |
| Scpharmaceuticals (SCPH) | 1.7 | $1.8M | 422k | 4.35 | |
| Aurinia Pharmaceuticals (AUPH) | 1.6 | $1.7M | 300k | 5.71 | |
| Milestone Pharmaceuticals (MIST) | 1.5 | $1.6M | 1.2M | 1.32 | |
| Aytu Biopharma (AYTU) | 1.3 | $1.4M | 473k | 2.92 | |
| Kiora Pharmaceuticals Com New | 0.8 | $840k | 200k | 4.20 | |
| Adicet Bio (ACET) | 0.7 | $737k | 609k | 1.21 | |
| Surrozen Com New (SRZN) | 0.7 | $724k | 66k | 10.95 | |
| Exagen (XGN) | 0.6 | $653k | 359k | 1.82 | |
| Kezar Life Sciences (KZR) | 0.6 | $630k | 1.1M | 0.60 | |
| Aprea Therapeutics Com New (APRE) | 0.5 | $558k | 137k | 4.07 | |
| 2seventy Bio (TSVT) | 0.4 | $385k | 100k | 3.85 | |
| Eton Pharmaceuticals (ETON) | 0.3 | $362k | 110k | 3.29 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.3 | $313k | 48k | 6.52 | |
| ACADIA Pharmaceuticals (ACAD) | 0.1 | $81k | 5.0k | 16.25 |
